Retatrutide

Retatrutide is an investigational triple-action peptide designed to target GLP-1, GIP, and glucagon receptors for advanced metabolic and weight management research. It is being studied for its potential to support appetite regulation, energy expenditure, fat metabolism, and improved glucose control. Due to its multi-receptor activity, Retatrutide has gained attention in scientific and pharmaceutical research focused on obesity, metabolic disorders, and long-term body weight management. Researchers are exploring its potential benefits in enhancing metabolic efficiency and supporting significant weight reduction outcomes.